Direct Oral Challenges in Private Practice Setting to Delabeling Children With Beta-lactam Allergy
Feasibility of Direct Oral Challenges in Private Practice Setting for the Evaluation of Mild Delayed Reactions to Beta-lactams in Children
Assistance Publique - Hôpitaux de Paris
200 participants
Jun 1, 2026
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to demonstrate the feasibility of direct oral challenge performed in private practice setting for children with suspected benign delayed allergy to beta-lactams. The results of this study could help establish recommendations for conducting direct oral challenge in primary care settings to delabeling children with benign delayed reactions to beta-lactams.
Eligibility
Inclusion Criteria5
- Population: Children's age between 0 and 17 years
- Child who has undergone a direct oral challenge in a private medical practice and a follow-up consultation within 7 to 14 days for suspected delayed allergy to amoxicillin +/- clavulanate or cefpodoxime or cefixime with the following characteristics:
- delayed reaction (onset > 1 hour after treatment start),
- mild reaction (isolated urticaria or Maculopapular exanthema),
- Absence of warning signs suggestive of a severe cutaneous adverse reaction (erythroderma, presence of bullae, vesicles, pustules, target lesions, involvement of oral, genital, or ocular mucosa, facial edema, general condition impairment, organ failure, duration > 7 days).
Exclusion Criteria1
- Informed children or holders of parental authority objecting to the use of patient data in the study.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07002814